A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy

NCT05889182 · clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
1328
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

AbbVie